Report Detail
Global Chinese Medicine Formula Granules Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4708441 |
- 17 June, 2026 |
- Global |
- 119 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Chinese Medicine Formula Granules market size was valued at US$ 15675 million in 2025 and is forecast to a readjusted size of US$ 36150 million by 2032 with a CAGR of 12.5% during review period.
Chinese Medicine Formula Granules are standardized granulated preparations produced from single-herb decoction pieces in compliance with pharmacopeia and processing standards, using modern pharmaceutical technologies such as extraction, concentration, purification, drying, and granulation. Prescribed and compounded by physicians under the guidance of traditional Chinese medicine (TCM) diagnostic principles, they are administered through oral dissolution. These granules represent the transformation of traditional decoctions into industrialized and standardized dosage forms, offering stable quality, precise dosing, convenience, and no need for decoction. With the continuous improvement of regulatory systems, they have become a key vehicle for TCM modernization, expanding their application in healthcare institutions and gradually replacing traditional herbal decoctions while driving industry standardization and globalization.The average gross profit margin of this product is 55%.
Supported by national policies promoting TCM innovation and healthcare system upgrades, the Chinese medicine formula granules industry is experiencing structural growth opportunities. The removal of pilot restrictions and the establishment of unified national standards have shifted the industry from a license-driven model to a capability-driven one, enhancing transparency and competition. Leading companies are leveraging their manufacturing expertise, distribution networks, and brand strength to expand nationwide, driving industry consolidation and scale expansion. Increasing demand from healthcare institutions for standardized, safe, and traceable medicines is further accelerating the clinical substitution of traditional decoctions. With stricter regulatory frameworks, the industry faces higher entry barriers and quality requirements. National standards impose tighter controls on active ingredients, raw material sourcing, and production consistency, requiring continuous investment in quality systems and technological upgrades. Transitional differences in standard implementation and product registration may lead to short-term supply fluctuations. In addition, volatility in herbal raw material prices, influenced by climate and supply-demand cycles, combined with supply chain uncertainties, creates pressure on cost control and profitability, accelerating market differentiation. On the demand side, Chinese medicine formula granules are expanding from traditional TCM hospitals to general hospitals, primary care institutions, and digital healthcare platforms. Rising patient acceptance of convenient and standardized medication is driving the replacement of traditional decoctions. Meanwhile, increasing demand for chronic disease management and personalized treatment is enhancing the penetration of TCM in community and home-based care. With the development of digital healthcare, an integrated model combining prescription granules, online consultation, and pharmaceutical services is emerging, transforming the industry toward comprehensive healthcare solutions. The industry fundamentally depends on the availability and quality of Chinese medicinal herbs. Policy support is driving upstream cultivation toward standardization, scale, and geo-authentic sourcing, with higher requirements for active ingredient content and traceability. However, herbal production remains highly sensitive to environmental factors, regional concentration, and cyclical supply-demand fluctuations, leading to price volatility. Leading companies are strengthening upstream control through proprietary cultivation bases, partnerships with producing regions, and supply chain integration, making raw material control a key competitive barrier.
This report is a detailed and comprehensive analysis for global Chinese Medicine Formula Granules market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chinese Medicine Formula Granules market size and forecasts, in consumption value ($ Million), 2021-2032
Global Chinese Medicine Formula Granules market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Chinese Medicine Formula Granules market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Chinese Medicine Formula Granules market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chinese Medicine Formula Granules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chinese Medicine Formula Granules market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangyin Tianjiang（China）, Tsumura & Co.（Japan）, Tianjin Hongri（China）, Sanjiu Medical（China）, Sichuan Neo-Green（China）, PuraPharm（Hong Kong, China）, Jilin Aodong（China）, China Shineway Pharmaceutical（China）, Anhui Jiren（China）, Guangdong Yifang（China）, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Chinese Medicine Formula Granules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single-ingredient Formula Granules
Compound Formula Granules
Market segment by End Users
Children
Adults
Elderly
Market segment by Therapeutic Area
Chronic Diseases
Respiratory Care
Digestive System
Others
Market segment by Application
Medical Institutions
Retail Pharmacy
Market segment by players, this report covers
Jiangyin Tianjiang（China）
Tsumura & Co.（Japan）
Tianjin Hongri（China）
Sanjiu Medical（China）
Sichuan Neo-Green（China）
PuraPharm（Hong Kong, China）
Jilin Aodong（China）
China Shineway Pharmaceutical（China）
Anhui Jiren（China）
Guangdong Yifang（China）
Jiangxi Baishen（China）
Heilongjiang Shuanglanxing（China）
Zhejiang Jingyuetang（China）
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chinese Medicine Formula Granules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chinese Medicine Formula Granules, with revenue, gross margin, and global market share of Chinese Medicine Formula Granules from 2021 to 2026.
Chapter 3, the Chinese Medicine Formula Granules competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Chinese Medicine Formula Granules market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chinese Medicine Formula Granules.
Chapter 13, to describe Chinese Medicine Formula Granules research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Chinese Medicine Formula Granules by Type
- 1.3.1 Overview: Global Chinese Medicine Formula Granules Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Chinese Medicine Formula Granules Consumption Value Market Share by Type in 2025
- 1.3.3 Single-ingredient Formula Granules
- 1.3.4 Compound Formula Granules
- 1.4 Classification of Chinese Medicine Formula Granules by End Users
- 1.4.1 Overview: Global Chinese Medicine Formula Granules Market Size by End Users: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Chinese Medicine Formula Granules Consumption Value Market Share by End Users in 2025
- 1.4.3 Children
- 1.4.4 Adults
- 1.4.5 Elderly
- 1.5 Classification of Chinese Medicine Formula Granules by Therapeutic Area
- 1.5.1 Overview: Global Chinese Medicine Formula Granules Market Size by Therapeutic Area: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Chinese Medicine Formula Granules Consumption Value Market Share by Therapeutic Area in 2025
- 1.5.3 Chronic Diseases
- 1.5.4 Respiratory Care
- 1.5.5 Digestive System
- 1.5.6 Others
- 1.6 Global Chinese Medicine Formula Granules Market by Application
- 1.6.1 Overview: Global Chinese Medicine Formula Granules Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Medical Institutions
- 1.6.3 Retail Pharmacy
- 1.7 Global Chinese Medicine Formula Granules Market Size & Forecast
- 1.8 Global Chinese Medicine Formula Granules Market Size and Forecast by Region
- 1.8.1 Global Chinese Medicine Formula Granules Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Chinese Medicine Formula Granules Market Size by Region, (2021-2032)
- 1.8.3 North America Chinese Medicine Formula Granules Market Size and Prospect (2021-2032)
- 1.8.4 Europe Chinese Medicine Formula Granules Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Chinese Medicine Formula Granules Market Size and Prospect (2021-2032)
- 1.8.6 South America Chinese Medicine Formula Granules Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Chinese Medicine Formula Granules Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Jiangyin Tianjiang（China）
- 2.1.1 Jiangyin Tianjiang（China） Details
- 2.1.2 Jiangyin Tianjiang（China） Major Business
- 2.1.3 Jiangyin Tianjiang（China） Chinese Medicine Formula Granules Product and Solutions
- 2.1.4 Jiangyin Tianjiang（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Jiangyin Tianjiang（China） Recent Developments and Future Plans
- 2.2 Tsumura & Co.（Japan）
- 2.2.1 Tsumura & Co.（Japan） Details
- 2.2.2 Tsumura & Co.（Japan） Major Business
- 2.2.3 Tsumura & Co.（Japan） Chinese Medicine Formula Granules Product and Solutions
- 2.2.4 Tsumura & Co.（Japan） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Tsumura & Co.（Japan） Recent Developments and Future Plans
- 2.3 Tianjin Hongri（China）
- 2.3.1 Tianjin Hongri（China） Details
- 2.3.2 Tianjin Hongri（China） Major Business
- 2.3.3 Tianjin Hongri（China） Chinese Medicine Formula Granules Product and Solutions
- 2.3.4 Tianjin Hongri（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Tianjin Hongri（China） Recent Developments and Future Plans
- 2.4 Sanjiu Medical（China）
- 2.4.1 Sanjiu Medical（China） Details
- 2.4.2 Sanjiu Medical（China） Major Business
- 2.4.3 Sanjiu Medical（China） Chinese Medicine Formula Granules Product and Solutions
- 2.4.4 Sanjiu Medical（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sanjiu Medical（China） Recent Developments and Future Plans
- 2.5 Sichuan Neo-Green（China）
- 2.5.1 Sichuan Neo-Green（China） Details
- 2.5.2 Sichuan Neo-Green（China） Major Business
- 2.5.3 Sichuan Neo-Green（China） Chinese Medicine Formula Granules Product and Solutions
- 2.5.4 Sichuan Neo-Green（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Sichuan Neo-Green（China） Recent Developments and Future Plans
- 2.6 PuraPharm（Hong Kong, China）
- 2.6.1 PuraPharm（Hong Kong, China） Details
- 2.6.2 PuraPharm（Hong Kong, China） Major Business
- 2.6.3 PuraPharm（Hong Kong, China） Chinese Medicine Formula Granules Product and Solutions
- 2.6.4 PuraPharm（Hong Kong, China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 PuraPharm（Hong Kong, China） Recent Developments and Future Plans
- 2.7 Jilin Aodong（China）
- 2.7.1 Jilin Aodong（China） Details
- 2.7.2 Jilin Aodong（China） Major Business
- 2.7.3 Jilin Aodong（China） Chinese Medicine Formula Granules Product and Solutions
- 2.7.4 Jilin Aodong（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Jilin Aodong（China） Recent Developments and Future Plans
- 2.8 China Shineway Pharmaceutical（China）
- 2.8.1 China Shineway Pharmaceutical（China） Details
- 2.8.2 China Shineway Pharmaceutical（China） Major Business
- 2.8.3 China Shineway Pharmaceutical（China） Chinese Medicine Formula Granules Product and Solutions
- 2.8.4 China Shineway Pharmaceutical（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 China Shineway Pharmaceutical（China） Recent Developments and Future Plans
- 2.9 Anhui Jiren（China）
- 2.9.1 Anhui Jiren（China） Details
- 2.9.2 Anhui Jiren（China） Major Business
- 2.9.3 Anhui Jiren（China） Chinese Medicine Formula Granules Product and Solutions
- 2.9.4 Anhui Jiren（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Anhui Jiren（China） Recent Developments and Future Plans
- 2.10 Guangdong Yifang（China）
- 2.10.1 Guangdong Yifang（China） Details
- 2.10.2 Guangdong Yifang（China） Major Business
- 2.10.3 Guangdong Yifang（China） Chinese Medicine Formula Granules Product and Solutions
- 2.10.4 Guangdong Yifang（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Guangdong Yifang（China） Recent Developments and Future Plans
- 2.11 Jiangxi Baishen（China）
- 2.11.1 Jiangxi Baishen（China） Details
- 2.11.2 Jiangxi Baishen（China） Major Business
- 2.11.3 Jiangxi Baishen（China） Chinese Medicine Formula Granules Product and Solutions
- 2.11.4 Jiangxi Baishen（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Jiangxi Baishen（China） Recent Developments and Future Plans
- 2.12 Heilongjiang Shuanglanxing（China）
- 2.12.1 Heilongjiang Shuanglanxing（China） Details
- 2.12.2 Heilongjiang Shuanglanxing（China） Major Business
- 2.12.3 Heilongjiang Shuanglanxing（China） Chinese Medicine Formula Granules Product and Solutions
- 2.12.4 Heilongjiang Shuanglanxing（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Heilongjiang Shuanglanxing（China） Recent Developments and Future Plans
- 2.13 Zhejiang Jingyuetang（China）
- 2.13.1 Zhejiang Jingyuetang（China） Details
- 2.13.2 Zhejiang Jingyuetang（China） Major Business
- 2.13.3 Zhejiang Jingyuetang（China） Chinese Medicine Formula Granules Product and Solutions
- 2.13.4 Zhejiang Jingyuetang（China） Chinese Medicine Formula Granules Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Zhejiang Jingyuetang（China） Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Chinese Medicine Formula Granules Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Chinese Medicine Formula Granules by Company Revenue
- 3.2.2 Top 3 Chinese Medicine Formula Granules Players Market Share in 2025
- 3.2.3 Top 6 Chinese Medicine Formula Granules Players Market Share in 2025
- 3.3 Chinese Medicine Formula Granules Market: Overall Company Footprint Analysis
- 3.3.1 Chinese Medicine Formula Granules Market: Region Footprint
- 3.3.2 Chinese Medicine Formula Granules Market: Company Product Type Footprint
- 3.3.3 Chinese Medicine Formula Granules Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Chinese Medicine Formula Granules Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Chinese Medicine Formula Granules Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Chinese Medicine Formula Granules Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Chinese Medicine Formula Granules Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Chinese Medicine Formula Granules Consumption Value by Type (2021-2032)
- 6.2 North America Chinese Medicine Formula Granules Market Size by Application (2021-2032)
- 6.3 North America Chinese Medicine Formula Granules Market Size by Country
- 6.3.1 North America Chinese Medicine Formula Granules Consumption Value by Country (2021-2032)
- 6.3.2 United States Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 6.3.3 Canada Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Chinese Medicine Formula Granules Consumption Value by Type (2021-2032)
- 7.2 Europe Chinese Medicine Formula Granules Consumption Value by Application (2021-2032)
- 7.3 Europe Chinese Medicine Formula Granules Market Size by Country
- 7.3.1 Europe Chinese Medicine Formula Granules Consumption Value by Country (2021-2032)
- 7.3.2 Germany Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 7.3.3 France Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 7.3.5 Russia Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 7.3.6 Italy Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Chinese Medicine Formula Granules Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Chinese Medicine Formula Granules Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Chinese Medicine Formula Granules Market Size by Region
- 8.3.1 Asia-Pacific Chinese Medicine Formula Granules Consumption Value by Region (2021-2032)
- 8.3.2 China Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 8.3.3 Japan Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 8.3.5 India Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 8.3.7 Australia Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Chinese Medicine Formula Granules Consumption Value by Type (2021-2032)
- 9.2 South America Chinese Medicine Formula Granules Consumption Value by Application (2021-2032)
- 9.3 South America Chinese Medicine Formula Granules Market Size by Country
- 9.3.1 South America Chinese Medicine Formula Granules Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Chinese Medicine Formula Granules Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Chinese Medicine Formula Granules Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Chinese Medicine Formula Granules Market Size by Country
- 10.3.1 Middle East & Africa Chinese Medicine Formula Granules Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
- 10.3.4 UAE Chinese Medicine Formula Granules Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Chinese Medicine Formula Granules Market Drivers
- 11.2 Chinese Medicine Formula Granules Market Restraints
- 11.3 Chinese Medicine Formula Granules Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Chinese Medicine Formula Granules Industry Chain
- 12.2 Chinese Medicine Formula Granules Upstream Analysis
- 12.3 Chinese Medicine Formula Granules Midstream Analysis
- 12.4 Chinese Medicine Formula Granules Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Chinese Medicine Formula Granules. Industry analysis & Market Report on Chinese Medicine Formula Granules is a syndicated market report, published as Global Chinese Medicine Formula Granules Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Chinese Medicine Formula Granules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
